Literature DB >> 20479510

The IPEM code of practice for determination of the reference air kerma rate for HDR (192)Ir brachytherapy sources based on the NPL air kerma standard.

A M Bidmead1, T Sander, S M Locks, C D Lee, E G A Aird, R F Nutbrown, A Flynn.   

Abstract

This paper contains the recommendations of the high dose rate (HDR) brachytherapy working party of the UK Institute of Physics and Engineering in Medicine (IPEM). The recommendations consist of a Code of Practice (COP) for the UK for measuring the reference air kerma rate (RAKR) of HDR (192)Ir brachytherapy sources. In 2004, the National Physical Laboratory (NPL) commissioned a primary standard for the realization of RAKR of HDR (192)Ir brachytherapy sources. This has meant that it is now possible to calibrate ionization chambers directly traceable to an air kerma standard using an (192)Ir source (Sander and Nutbrown 2006 NPL Report DQL-RD 004 (Teddington: NPL) http://publications.npl.co.uk). In order to use the source specification in terms of either RAKR, Κ(R) (ICRU 1985 ICRU Report No 38 (Washington, DC: ICRU); ICRU 1997 ICRU Report No 58 (Bethesda, MD: ICRU)), or air kerma strength, S(K) (Nath et al 1995 Med. Phys. 22 209-34), it has been necessary to develop algorithms that can calculate the dose at any point around brachytherapy sources within the patient tissues. The AAPM TG-43 protocol (Nath et al 1995 Med. Phys. 22 209-34) and the 2004 update TG-43U1 (Rivard et al 2004 Med. Phys. 31 633-74) have been developed more fully than any other protocol and are widely used in commercial treatment planning systems. Since the TG-43 formalism uses the quantity air kerma strength, whereas this COP uses RAKR, a unit conversion from RAKR to air kerma strength was included in the appendix to this COP. It is recommended that the measured RAKR determined with a calibrated well chamber traceable to the NPL (192)Ir primary standard is used in the treatment planning system. The measurement uncertainty in the source calibration based on the system described in this COP has been reduced considerably compared to other methods based on interpolation techniques.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20479510     DOI: 10.1088/0031-9155/55/11/011

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  6 in total

1.  A dosimetric uncertainty analysis for photon-emitting brachytherapy sources: report of AAPM Task Group No. 138 and GEC-ESTRO.

Authors:  Larry A DeWerd; Geoffrey S Ibbott; Ali S Meigooni; Michael G Mitch; Mark J Rivard; Kurt E Stump; Bruce R Thomadsen; Jack L M Venselaar
Journal:  Med Phys       Date:  2011-02       Impact factor: 4.071

Review 2.  Air kerma and absorbed dose standards for reference dosimetry in brachytherapy.

Authors:  T Sander
Journal:  Br J Radiol       Date:  2014-07-07       Impact factor: 3.039

Review 3.  Dosimetric audit in brachytherapy.

Authors:  A L Palmer; D A Bradley; A Nisbet
Journal:  Br J Radiol       Date:  2014-05-06       Impact factor: 3.039

4.  Source strength determination in iridium-192 and cobalt-60 brachytherapy: A European survey on the level of agreement between clinical measurements and manufacturer certificates.

Authors:  Javier Vijande; Åsa Carlsson Tedgren; Facundo Ballester; Dimos Baltas; Panagiotis Papagiannis; Mark J Rivard; Frank-André Siebert; Larry De Werd; Jose Perez-Calatayud
Journal:  Phys Imaging Radiat Oncol       Date:  2021-07-30

Review 5.  Ir-192 Calibration in Air with Farmer Chamber for HDR Brachytherapy.

Authors:  Liyun Chang; Sheng-Yow Ho; Tsair-Fwu Lee; Hueisch-Jy Ding; Pang-Yu Chen
Journal:  J Med Biol Eng       Date:  2016-03-31       Impact factor: 1.553

6.  A survey of quality control practices for high dose rate (HDR) and pulsed dose rate (PDR) brachytherapy in the United Kingdom.

Authors:  Antony L Palmer; Margaret Bidmead; Andrew Nisbet
Journal:  J Contemp Brachytherapy       Date:  2012-12-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.